Brian Wagner
Foot Surgery · Farmington, CTNPI 1093743502
Payments from drug & device makers
What this record shows
11 manufacturers reported payments, led by Gramercy Extremity Orthopedics LLC at 42.7% of the total. Reporting peaked in 2021 at $501 and has fallen 96.1% since, to $19 in 2025.
Across 13 payments — averaging $76.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gramercy Extremity Orthopedics LLC$425
- Axogen$136
- KCI USA, Inc.$91
- Zimvie Inc.$83
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$76
- Osiris Therapeutics Inc.$72
- plus $112 from 5 others
What the payments were for
- Consulting fees$42543%
- Food & beverage$57157%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gramercy Extremity Orthopedics LLC | 1 | $425 |
| Axogen | 2 | $136 |
| KCI USA, Inc. | 1 | $91 |
| Zimvie Inc. | 2 | $83 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $76 |
| Osiris Therapeutics Inc. | 1 | $72 |
| Averitas Pharma Inc. | 1 | $33 |
| Pacira Pharmaceuticals Incorporated | 1 | $22 |
| Treace Medical Concepts, Inc. | 1 | $19 |
| Smith+Nephew | 1 | $19 |
| Convatec Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$996 in reported general payments places this provider in the 55th percentile of 20 foot surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 119 | $2,791 |
| Gabapentin | 177 | $2,781 |
| Pentoxifylline | 80 | $1,926 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 21 | $1,885 |
| Terbinafine Hcl | 251 | $1,076 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 23 | $1,044 |
| Ammonium Lactate | 54 | $956 |
| Ketoconazole | 26 | $912 |
| Celecoxib | 18 | $869 |
| Clotrimazole | 19 | $527 |
| Doxycycline Hyclate | 44 | $520 |
| Fluocinonide | 11 | $499 |
| Colchicine | 13 | $477 |
| Cephalexin | 25 | $357 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 38 | $275 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Farmington
- Farlyn Charlot-WadleyNew Haven$4K
- Raffaella PascarellaBloomfield$4K
- Manal AnzShelton$4K
- Leo VeleasSouthington$2K
- Anthony BabigianNorwalk$2K
- Catherine JacobsHartford$1K
- Benedict ValentineMarlborough$1K
- Marissa GirolamoStamford$1K
- Richard DurocherNorth Haven$962
- Michael ScanlonWillimantic$958
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.